Journal
JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY
Volume 46, Issue 4, Pages 605-610Publisher
CHURCHILL LIVINGSTONE
DOI: 10.1016/j.jcms.2017.12.016
Keywords
Oral squamous cell carcinoma; Cancer-associated fibroblasts; p62; Chemotherapy
Categories
Funding
- Natural Science Foundation of Guangdong Province [2014A030310076]
- Science and Technology Project of Guangdong Province [2016A020215031]
Ask authors/readers for more resources
Purpose: The aim of this study is to investigate the expression of the autophagy protein p62 in oral squamous cell carcinoma (OSCC) cells before and after chemotherapy. We also detected cancer-associated fibroblasts (CAFs) in these OSCC samples to explore the roles of p62 and CAFs in chemotherapy. Materials and methods: Immunohistochemistry was used to analyze the expression of p62 and alpha-SMA in 26 paired OSCC samples before and after chemotherapy. The relationships between clinicopathological features, clinical outcome and the expression of these proteins were analyzed. Results: Our results indicated an increased stromal a-SMA expression after chemotherapy in OSCC samples. High p62 expression of OSCC cells closely correlated with stromal a-SMA expression after chemotherapy. Furthermore, the post-chemotherapy p62 expression was associated with the prognosis for OSCC patients. Conclusion: These results suggest that chemotherapy may increase CAFs in OSCC. High cytoplasmic p62 expression may serve as a poor prognostic marker for OSCC patients. (C) 2017 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available